FDA Offers Advice on Assays for COVID-19 Therapeutic Proteins

The FDA issued straight-to-final guidance that provides sponsors of monoclonal antibody and other therapeutic protein COVID-19 treatments with recommendations for potency assays to ensure consistent product quality.
Source: Drug GMP Report